Suchergebnisse - "Mayo, Marlyn J"

PubPharm (124)

1

Advances in the evaluation and treatment of autoimmune hepatitis

enthalten in: Current opinion in gastroenterology | 2024

von Pedersen, M. | Mayo, M.

2

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Kowdley, K. | Bowlus, C. | Levy, C. | +102

3

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Hirschfield, G. | Bowlus, C. | Mayo, M. | +94

4

Open-label, clinical trial extension : Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

5

Editorial : The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C.

6

Open‐label, clinical trial extension : Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

7

Editorial : The evolving paradigms and treatments for primary biliary cholangitis—Authors' reply

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C.

8

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

9

Systemic Complications of Primary Biliary Cholangitis

enthalten in: Clinics in liver disease | 2024

von Zapata, M. | Pagan-Torres, H. | Mayo, M.

10

Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Kremer, A. | Mayo, M. | Hirschfield, G. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]